M.D. Greg Keenan - 02 Feb 2026 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Signature
/s/ Greg Keenan, M.D.
Issuer symbol
AUPH
Transactions as of
02 Feb 2026
Net transactions value
-$167,851
Form type
4
Filing time
03 Feb 2026, 16:49:18 UTC
Previous filing
05 Aug 2025
Next filing
03 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Keenan Greg SVP, Chief Medical Officer #140, 14315 - 118 AVENUE, EDMONTON, ALBERTA, CANADA /s/ Greg Keenan, M.D. 03 Feb 2026 0002044006

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Stock Tax liability $167,851 -11,552 -8.7% $14.53 121,932 02 Feb 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units.